Literature DB >> 11750226

Immune control of Brucella abortus 2308 infections in BALB/c mice.

E A Murphy1, M Parent, J Sathiyaseelan, X Jiang, C L Baldwin.   

Abstract

BALB/c mice infected with Brucella abortus strain 2308 have 10-fold higher levels of bacteria during the plateau phase of infection (the time period when the number of colony-forming units in vivo remains consistent) than the more resistant C57BL/10 mice. This is due to a cessation of interferon-gamma (IFN-gamma) production that begins after the first week of infection and continues until the end of the plateau phase at least 6 weeks post infection. Despite the lack of IFN-gamma production during this time BALB/c mice are able to prevent an increase in bacterial colony-forming units. Here it was shown that both tumor necrosis factor (TNF)-alpha and CD8 T cells were involved in controlling bacterial numbers in BALB/c mice during this time. That is, neutralization of TNF-alpha or depletion of CD8 T cells with monoclonal antibodies resulted in a significant increase in the number of splenic colony-forming units recovered at 3 weeks post infection. In the absence of CD8 T cells there was also a significant increase in splenic macrophages. The role of TNF-alpha may depend upon the presence of interferon-gamma early in the infection since when TNF-alpha was neutralized in interferon-gamma gene knockout mice there was a marked increase in splenic macrophages, NK cells and neutrophils but not a significant increase in colony-forming units.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750226     DOI: 10.1111/j.1574-695X.2001.tb00536.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  25 in total

1.  Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

Authors:  S Segura; C Gamazo; J M Irache; S Espuelas
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.

Authors:  M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.

Authors:  Juliana Cassataro; Carlos A Velikovsky; Silvia de la Barrera; Silvia M Estein; Laura Bruno; Raúl Bowden; Karina A Pasquevich; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  The Brucella abortus Cu,Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice.

Authors:  Jason M Gee; Michelle Wright Valderas; Michael E Kovach; Vanessa K Grippe; Gregory T Robertson; Wai-Leung Ng; John M Richardson; Malcolm E Winkler; R Martin Roop
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages.

Authors:  Yongqun He; Sherry Reichow; Sheela Ramamoorthy; Xicheng Ding; Raju Lathigra; Johanna C Craig; Bruno W S Sobral; Gerhardt G Schurig; Nammalwar Sriranganathan; Stephen M Boyle
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

8.  Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.

Authors:  Marie-Alice Vitry; Carl De Trez; Stanislas Goriely; Laure Dumoutier; Shizuo Akira; Bernhard Ryffel; Yves Carlier; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

9.  Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice.

Authors:  Laurence A Guilloteau; Jacques Dornand; Antoine Gross; Michel Olivier; Fabienne Cortade; Yves Le Vern; Dominique Kerboeuf
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.

Authors:  Angello Retamal-Díaz; Roberto Riquelme-Neira; Darwin Sáez; Alejandra Rivera; Pablo Fernández; Alex Cabrera; Carlos A Guzmán; Angel Oñate
Journal:  Clin Vaccine Immunol       Date:  2014-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.